The ADC Challenge, Lung Cancer Edition: What, When, How? Interpreting the Evidence on NovelAntibody-Drug Conjugates and Comparing Expert and Artificial Intelligence Responses to Questions About Patient Selection, Clinical Integration, and Other Practicalities
- Provider:PVI, PeerView Institute for Medical Education
- Activity Link: https://www.peerview.com
- Start Date: 2025-02-20 06:00:00
- End Date: 2025-02-20 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABIM - 1.0 Point; Credit Type(s): Patient Safety (ABIM) - Commercial Support: Source: AstraZeneca (Any division) - Amount: 0 - Is Kind Support: False Source: Daiichi Sankyo, Inc. - Amount: 0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest